You are here: Industry Insights > USP

News List

What are the requirements of USP for tablet form of oral dosage <1062>? Muhammad Asim Niazi
June 14, 2023
Chapter 1062, written as USP <1062>, TABLET COMPRESSION CHARACTERIZATION, provides guidelines for the tablet form of dosages. It also offers some insight into common problems during the compression process and how these can be solved.
Dr. Reddy's Laboratories Launches Valsartan Tablets, USP in the U.S. Market AmericanPharmaceuticalReview
December 10, 2021
Dr. Reddy’s Laboratories Ltd. announced the launch of Valsartan Tablets, USP, a therapeutic equivalent generic version of Diovan® (valsartan) Tablets approved by the U.S. Food and Drug Administration (USFDA).
Sagent Pharmaceuticals Recalls Levetiracetam Injection, USP Due to Lack of Sterility Assurance AmericanPharmaceuticalReview
December 01, 2021
Sagent Pharmaceuticals, Inc. announced the voluntary nationwide recall of four lots of Levetiracetam Injection, USP, to the user level. The lack of container closure integrity, found in reserve sample vials may result in a non-sterile product.
United States Pharmacopeia Acquires Pharmatech Associates contractpharma
July 12, 2021
Expanded offerings will help regulated life science companies strengthen the supply chain for safe, quality medicines.
USP to release <922> Water Activity method for pharma europeanpharmaceuticalreview
April 20, 2021
The new chapter, to be released in May, highlights the benefits of water activity measurement, as well as potential applications and best practices for use in pharmaceutical manufacturing.
Collaboration to encourage US adoption of continuous manufacturing europeanpharmaceuticalreview
April 14, 2021
USP and Phlow have built a new laboratory to develop test methods and standards to facilitate broader adoption of continuous manufacturing in the US.
Phlow Corp. and USP Form Alliance contractpharma
March 02, 2021
Focused on continuous manufacturing to increase supply of essential medicines for U.S. patients.
USP Expands Alcohol-based Hand Sanitizer Support in Response to Quality Incidents americanpharmaceuticalreview
February 08, 2021
In response to the alcohol-based hand sanitizer quality incidents reported across the globe, the U.S. Pharmacopeia (USP) is offering free access to USP-NF standards, information and on-demand education related to producing quality alcohol-based hand ...
USP Launches Trust Accelerated Program to Help COVID-19 Treatment, Vaccine Development americanpharmaceuticalreview
May 14, 2020
To accelerate the development of safe and effective COVID-19 vaccines, medicines and other treatments, the U.S. Pharmacopeia (USP) has launched a new program to support scientists, developers and manufacturers worldwide.
USP Offers Hand Sanitizer Toolkit in Response to COVID-19 Pandemic americanpharmaceuticalreview
April 07, 2020
The U.S. Pharmacopeia (USP) is offering an online toolkit with guidelines from major public health organizations on compounding alcohol-based hand sanitizers and the preparation of hand sanitizers by manufacturers, pharmacies and other facilities.

Previous page 1 2 3 Next page